Site menu

Search by ticker code:
Generic filters

Menu

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

HY21 result: InvoCare (ASX:IVC) share price jumps 8%

The InvoCare Limited (ASX: IVC) share price has gone up 8% after releasing its FY21 half-year result.

InvoCare’s FY21 half-year result

Invocare reported that its revenue increased by 13% to $260.9 million.

The company said that in Australia, operating revenue has grown in all markets with a 6.6% increase in operating revenue, driven by a 6.7% increase in funeral prices, while volumes were in line with the prior corresponding period.

In New Zealand, there was a 5.8% increase in operating revenue to $26.3 million. Singapore revenue, in local currency terms, increased by 3.4% to S$9.5 million.

The funeral operator said that total operating EBITDA (EBITDA explained) grew by 31% to $63.6 million. Management pointed out there was a return to positive operating leverage. Operating EBIT grew 46% to $39.4 million.

The operating profit / earnings per share (EPS) went up 57% to 14.4 cents.

Dividend

InvoCare’s board decided to pay an interim dividend of 9.5 cents per share, which was a dividend payout ratio of 66%. This was an increase of 72.7% compared to a year ago.

Outlook for InvoCare and the share price

InvoCare warned that the Delta variant spread in Australia is expected to lead to a softening of the funeral services market in the second half of 2021. So management couldn’t provide guidance.

But, management are confident about the long-term potential of the business, with future growth supported by population and ageing trends in its operating markets.

InvoCare said that it will continue to leverage its national footprint in pet cremations with national supply agreements with key veterinary groups.

The company is also doing a number of initiatives to strengthen its position as it aims to lead the industry when it comes to sustainability, innovation and community engagement.

Management said that this FY21 first half result was a sign of the strength of the business when conditions permitted.

InvoCare is an interesting business. As the saying goes, there are only two things certain in life – death and taxes. The company is expected to benefit from the ageing demographics.

But it’s not exactly cheap at 35 times the estimated earnings for the 2022 financial year, according to CommSec numbers.

If you’re looking to learn how to do your own ASX company valuations, take our free share valuation course, which takes you through 6 common share valuation techniques, step by step. Or try our Beginner Shares Course if you’re just starting out. Both are free.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.
Skip to content